NYFSGIBN NYSE FactSet Global Genomics and Immuno Biopharma Index
The Index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
0.00
As of 02/08/2023
Index Information
Provider:
ICE (NYSE)
Category1: Global Equity
Category2: Single industry
Category3: Healthcare
Currency: USD
Inception date: 01/01/1900
Backtesting data exists:
Weighting methodology: Market capitalization
Number of holdings: 48
(as of 01/20/2020)
As explained in
what is an index, there is no universal system of giving an index a symbol.
You can search for indexes using our
index symbol lookup.